Reported 18,376,046 shares, up 677,741 (3.8%) from the prior quarter.
Reported value 3.4%; share count 3.8% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 930000 |
| 2022-03-31 | 587000 |
| 2022-06-30 | 594000 |
| 2022-09-30 | 405000 |
| 2022-12-31 | 563614 |
| 2023-03-31 | 14794298 |
| 2023-06-30 | 11684682 |
| 2023-09-30 | 10680093 |
| 2023-12-31 | 17460282 |
| 2024-03-31 | 22782167 |
| 2024-06-30 | 64767230 |
| 2024-09-30 | 83577536 |
| 2024-12-31 | 73859222 |
| 2025-03-31 | 83035438 |
| 2025-06-30 | 74661764 |
| 2025-09-30 | 111005778 |
| 2025-12-31 | 128440353 |
| 2026-03-31 | 116511663 |
| 2026-06-30 | 84951868 |
| 2026-09-30 | 87837503 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 18,376,046 | +677,741 (3.8%) | < 0.01% | $87,837,503 | 2026-11-13 | |
| Q2 2026 | Reduced | 17,698,305 | -8,193,175 (-31.6%) | < 0.01% | $84,951,868 | 2026-08-13 | |
| Q1 2026 | Reduced | 25,891,480 | -811,296 (-3.0%) | < 0.01% | $116,511,663 | 2026-05-15 | |
| Q4 2025 | Added | 26,702,776 | +2,252,164 (9.2%) | < 0.01% | $128,440,353 | 2026-02-13 | |
| Q3 2025 | Added | 24,450,612 | +288,229 (1.2%) | < 0.01% | $111,005,778 | 2025-11-14 | |
| Q2 2025 | Added | 24,162,383 | +369,994 (1.6%) | < 0.01% | $74,661,764 | 2025-08-15 | |
| Q1 2025 | Added | 23,792,389 | +1,205,471 (5.3%) | < 0.01% | $83,035,438 | 2025-05-15 | |
| Q4 2024 | Added | 22,586,918 | +878,467 (4.0%) | < 0.01% | $73,859,222 | 2025-02-14 | |
| Q3 2024 | Added | 21,708,451 | +748,183 (3.6%) | < 0.01% | $83,577,536 | 2024-11-14 | |
| Q2 2024 | Added | 20,960,268 | +12,129,971 (137.4%) | < 0.01% | $64,767,230 | 2024-08-14 | |
| Q1 2024 | Added | 8,830,297 | +1,846,185 (26.4%) | < 0.01% | $22,782,167 | 2024-05-15 | |
| Q4 2023 | Added | 6,984,112 | +1,722,982 (32.7%) | < 0.01% | $17,460,282 | 2024-02-13 | |
| Q3 2023 | Added | 5,261,130 | +180,834 (3.6%) | < 0.01% | $10,680,093 | 2023-11-15 | |
| Q2 2023 | Added | 5,080,296 | +197,689 (4.0%) | < 0.01% | $11,684,682 | 2023-08-14 | |
| Q1 2023 | Added | 4,882,607 | +4,640,713 (1918.5%) | < 0.01% | $14,794,298 | 2023-05-15 | |
| Q4 2022 | Added | 241,894 | +29,888 (14.1%) | < 0.01% | $563,614 | 2023-02-14 | |
| Q3 2022 | Reduced | 212,006 | -6,667 (-3.0%) | < 0.01% | $405,000 | 2022-11-14 | |
| Q2 2022 | Added | 218,673 | +21,492 (10.9%) | < 0.01% | $594,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 197,181 | -41,826 (-17.5%) | < 0.01% | $587,000 | 2022-05-13 | |
| Q4 2021 | Added | 239,007 | +17,823 (8.1%) | < 0.01% | $930,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
234 managers reported ARBUTUS BIOPHARMA CORP for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| MORGAN STANLEY This report | Added | 18,376,046 | +677,741 | < 0.01% | $87,837,503 | 45 qtrs |
| BlackRock Inc | Added | 14,515,428 | +749,357 | < 0.01% | $69,383,746 | 9 qtrs |
| NOMURA HOLDINGS INC | Added | 14,512,000 | +12,874,919 | 0.08% | $69,367,360 | 6 qtrs |
| Two Seas Capital LP | Reduced | 8,143,994 | -10,951,589 | 0.45% | $38,928,291 | 20 qtrs |
| STATE STREET CORPORATION | Reduced | 7,081,502 | -787,677 | < 0.01% | $33,849,580 | 45 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 6,988,183 | -22,496 | < 0.01% | $33,403,515 | 3 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 4,121,119 | +3,428 | < 0.01% | $19,703,115 | 45 qtrs |
| Rubric Capital Management LP | Reduced | 3,343,932 | -4,189,005 | 0.15% | $15,983,995 | 10 qtrs |
| MILLENNIUM MANAGEMENT LLC | New | 3,061,019 | +3,061,019 | < 0.01% | $14,631,671 | 30 qtrs |
| The Goldman Sachs Group Inc | Reduced | 2,580,551 | -926,251 | < 0.01% | $12,335,034 | 45 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 13, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 17,735,544
- Shared
- 615,386
- None
- 25,116
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.